Mengzhen Li

1.5k citations
58 papers · 686 indexed · h-index 17
Topics
Cancer-related molecular mechanisms research (5 papers)Cholinesterase and Neurodegenerative Diseases (5 papers)RNA modifications and cancer (4 papers)
Journals
SHILAP Revista de lepidopterologíaACS NanoAnalytical Chemistry

In The Last Decade

Mengzhen Li

53 papers receiving 681 citations

Peers

Mengzhen Li
Comparison fields: 5 of 98
  • Molecular Biology 380
  • Cancer Research 181
  • Oncology 109
  • Pulmonary and Respiratory Medicine 94
  • Immunology 55
Replace İbrahim Tekedereli with:
İbrahim Tekedereli Türkiye
Qi Huang China
Zhilin Zou China
Can‐Can Zheng China
Kecheng Lei China
Yasmine Kanaan United States
Qichao Qi China
Fantian Zeng China
Lan Yang China
Mengzhen Li relative to İbrahim Tekedereli Türkiye İbrahim Tekedereli's profile →
Citations per field
00.5×2.9×
İbrahim Tekedereli · 1×
Citations per year

Countries citing papers authored by Mengzhen Li

Since Specialization
Citations

This map shows the geographic impact of Mengzhen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengzhen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengzhen Li more than expected).

Fields of papers citing papers by Mengzhen Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengzhen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengzhen Li. The network helps show where Mengzhen Li may publish in the future.

Co-authorship network of co-authors of Mengzhen Li

This figure shows the co-authorship network connecting the top 25 collaborators of Mengzhen Li. A scholar is included among the top collaborators of Mengzhen Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengzhen Li. Mengzhen Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 3
4 3
5 1
6 7
7 6
8 2
9 2
10 8
11 8
12 23
13 18
14 8
15 6
16 13
17 19
18 90
19 55
20 20

About Mengzhen Li

Mengzhen Li is a scholar working on Biological Psychiatry, Cancer Research and Reproductive Medicine, having authored 58 papers that have together received 686 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), Cholinesterase and Neurodegenerative Diseases (5 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Cancer Research (181 citations), Molecular Biology (380 citations) and Biological Psychiatry (10 citations). Mengzhen Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Zhangwei Tong, Chundong Yu, Bing Shen, Kesong Peng, Jun Yan, Liping Qin, Shangwu Chen, Lian‐Wen Qi, Shujun Jiang and Yizhuo Zhang. Their work appears in journals such as SHILAP Revista de lepidopterología, ACS Nano and Analytical Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026